ObsEva

$9.70
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.45 (4.86%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell ObsEva and other stocks, options, ETFs, and crypto commission-free!

About OBSV

ObsEva SA engages in the development of therapeutic treatments for woman's reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. Read More The company was founded by Ernest Loumaye and André Chollet in November 2012 and is headquartered in Geneva, Switzerland.

Employees
Headquarters
Geneva, Geneve (Geneva)
Founded
2012
Market Cap
424.08M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
28.40K
High Today
$9.76
Low Today
$9.27
Open Price
$9.27
Volume
75.08K
52 Week High
$19.40
52 Week Low
$8.22

Collections

OBSV News

ReutersAug 17

Edited Transcript of OBSV.O earnings conference call or presentation 7-Aug-19 12:00pm GMT

3

OBSV Earnings

-$0.80
-$0.67
-$0.55
-$0.42
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 6, Pre-Market

Popular Stocks

More OBSV News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.